TropIQ co-authored a publication in NPJ Drug Discovery on prioritisation of novel molecular targets for malaria drug discovery. Advanced bioinformatics was followed by a heroic effort where a large group of collaborators provide expert review and rubric-based scoring of 540 potential targets. The results prioritised targets for drug discovery in the context of the Malaria Drug Accelerator consortium, of which TropIQ is a proud contributor.
Read more here.